FOR IMMEDIATE RELEASE: December 3, 2020
Contact: Prudence Robertson, email@example.com, 240-672-2828
Several Used Abortion-Derived Cell Lines in Testing; Experts Urge All Vaccine Developers to Use Noncontroversial Alternatives
Washington, D.C. – Today Charlotte Lozier Institute (CLI) published a new chart detailing whether the eight leading COVID-19 vaccine candidates supported by Operation Warp Speed are produced or tested using cells derived from abortions. The vaccine candidates evaluated are those produced by Pfizer/BioNTech, Moderna, AstraZeneca, Johnson & Johnson, Novavax, Sanofi/GSK, Inovio, and Merck.
CLI’s analysis found that a majority of vaccine candidates did not use abortion-derived cell lines in their production. Several used abortion-derived cell lines in laboratory testing, or their use in testing could not be determined.
CLI offered the following additional statement:
“CLI’s expert scientific analysis finds that many leading vaccine candidates supported by Operation Warp Speed do not use abortion-derived cell lines in their production. This is encouraging news.
“Unfortunately, some vaccine developers have unnecessarily put American families in a difficult position by choosing to use controversial human fetal cell lines in production or testing, or by a lack of transparency. Many developers already opt to use animal cell lines, non-fetal human cells, yeast, or chicken eggs instead. We urge all developers to avail themselves of these options going forward. Doing so will reduce vaccine hesitancy for those who oppose the use of fetal cell lines, thereby increasing the public health impact of the vaccine.
“It remains to be seen which vaccines will be approved for emergency use and how soon they will be available to patients. CLI will continue to provide the public with access to timely and accurate information so that individuals and families can weigh all factors – including secular science and religious traditions – and make vaccine decisions in line with their conscience.”
CLI Vice President Dr. David Prentice, and Director of Life Sciences Dr. Tara Sander Lee are available to discuss with media. To request an interview, please contact Prudence Robertson at firstname.lastname@example.org or 240-672-2828.
DISCLAIMER: THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE
The information, including but not limited to, text, graphics, images and other material contained on this website are for educational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.
Charlotte Lozier Institute was launched in 2011 as the education and research arm of Susan B. Anthony List. CLI is a hub for research and public policy analysis on some of the most pressing issues facing the United States and nations around the world. The Institute is named for a feminist physician known for her commitment to the sanctity of human life and equal career and educational opportunities for women. The 175th anniversary of Dr. Charlotte Denman Lozier’s birth occurred on March 16, 2019.